Skin cancer drug Nidlegy shows positive results in Phase III trial
Italian-Swiss biotechnology company Philogen and Sun Pharmaceutical announced positive results from the Phase III “Pivotal” trial of Nidlegy on locally advanced melanoma. Nidlegy is Philogen’s prorpietary product to treat skin…